1. Home
  2. CSBR vs NSPR Comparison

CSBR vs NSPR Comparison

Compare CSBR & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

N/A

Current Price

$5.87

Market Cap

82.7M

Sector

Health Care

ML Signal

N/A

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.49

Market Cap

72.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSBR
NSPR
Founded
1985
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.7M
72.1M
IPO Year
2015
2009

Fundamental Metrics

Financial Performance
Metric
CSBR
NSPR
Price
$5.87
$1.49
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
8.2K
40.0K
Earning Date
03-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
161.11
N/A
EPS
N/A
N/A
Revenue
$2,900,000.00
$2,310,000.00
Revenue This Year
$4.84
$57.98
Revenue Next Year
$11.51
$95.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.50
$1.38
52 Week High
$9.63
$2.93

Technical Indicators

Market Signals
Indicator
CSBR
NSPR
Relative Strength Index (RSI) 54.21 35.03
Support Level $6.11 N/A
Resistance Level $6.29 $2.51
Average True Range (ATR) 0.25 0.12
MACD 0.04 -0.03
Stochastic Oscillator 76.61 11.54

Price Performance

Historical Comparison
CSBR
NSPR

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

Share on Social Networks: